Responses
Late-Breaking Abstracts
Clinical Trial Completed
1521 Identification of microenvironment features associated with primary resistance to anti-PD-1/PD-L1 + antiangiogenesis in gastric cancer: a joint analysis of the REGOMUNE and REGONIVO studies
Compose a Response to This Article
Other responses
No responses have been published for this article.
